Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Genetic association with response to intravitreal ranibizumab for neovascular age-related macular degeneration in the Han Chinese population.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: Yuan D;Yuan D; Yuan D; Liu X; Yuan S; Xie P; Liu Q
  • المصدر:
    Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift fur Augenheilkunde [Ophthalmologica] 2013; Vol. 230 (4), pp. 227-32. Date of Electronic Publication: 2013 Sep 25.
  • نوع النشر :
    Journal Article; Research Support, Non-U.S. Gov't
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: Karger Country of Publication: Switzerland NLM ID: 0054655 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0267 (Electronic) Linking ISSN: 00303755 NLM ISO Abbreviation: Ophthalmologica Subsets: MEDLINE
    • بيانات النشر:
      Publication: Basel : Karger
      Original Publication: Basel.
    • الموضوع:
      Polymorphism, Single Nucleotide*; Angiogenesis Inhibitors/*therapeutic use ; Antibodies, Monoclonal, Humanized/*therapeutic use ; Serine Endopeptidases/*genetics ; Vascular Endothelial Growth Factor A/*genetics ; Wet Macular Degeneration/*drug therapy; Aged ; Aged, 80 and over ; Asian People/genetics ; China ; Complement Factor H/genetics ; Female ; Genotype ; High-Temperature Requirement A Serine Peptidase 1 ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Ranibizumab ; Visual Acuity/physiology ; Wet Macular Degeneration/genetics
    • نبذة مختصرة :
      Purpose: To investigate a possible association between gene variants and patient response to treatment with intravitreal ranibizumab for neovascular age-related macular degeneration (AMD).
      Methods: Visual acuity score (VAS) was recorded at baseline and a subsequent visit at 6 months. Genotypes of 3 polymorphisms in known AMD susceptibility loci (rs1061170 in complement factor H (CFH), rs11200638 in HTRA1 and rs1413711 in VEGF) were determined. Central retinal thickness and maximum thickness of the lesion were also measured.
      Results: A total of 168 neovascular AMD patients treated with intravitreal ranibizumab were included in our study. For HTRA1 rs11200638, mean VAS changes were 3.5, 9.4 and 10.6 letters for the AA, AG and GG genotypes, respectively (p = 0.022). In contrast, for CFH rs1061170 and VEGF rs1413711, mean VAS changes were not significant. However, there was no significant difference in the changes in central retinal thickness and maximum lesion thickness among the genotypes of the tested single-nucleotide polymorphisms.
      Conclusions: HTRA1 gene polymorphism may influence patient response to treatment with intravitreal ranibizumab for neovascular AMD.
      (© 2013 S. Karger AG, Basel.)
    • الرقم المعرف:
      0 (Angiogenesis Inhibitors)
      0 (Antibodies, Monoclonal, Humanized)
      0 (CFH protein, human)
      0 (VEGFA protein, human)
      0 (Vascular Endothelial Growth Factor A)
      80295-65-4 (Complement Factor H)
      EC 3.4.21.- (High-Temperature Requirement A Serine Peptidase 1)
      EC 3.4.21.- (HTRA1 protein, human)
      EC 3.4.21.- (Serine Endopeptidases)
      ZL1R02VT79 (Ranibizumab)
    • الموضوع:
      Date Created: 20131002 Date Completed: 20140709 Latest Revision: 20231213
    • الموضوع:
      20240829
    • الرقم المعرف:
      10.1159/000355068
    • الرقم المعرف:
      24080590